Abstract Library

#2122 Is the EORTC QLQ-QNET21 Optimal for Patients with Neuroendocrine Tumors?

Introduction: Quality of life (QoL) is important to all cancer patients. The EORTC QLQ-QNET21 is the most commonly used questionnaire in patients with neuroendocrine tumors (NETs).

Conference: 15th Annual ENETSConcerence (2018)

Presenting Author: van Leeuwaarde R

Authors: Van Leeuwaarde R, Spada F, Cheung W, Gonzalez-Clavijo A, Pracht M,

Keywords: Quality of life, GEP-NET, EORTC QLQ-GINET21,

#1858 Quality of Life in Patients with Multiple Endocrine Neoplasia Type I (MEN1): Results from the Dutch MEN1 Study Group

Introduction: Multiple Endocrine neoplasia type 1 (MEN1) is a hereditary tumor syndrome, characterized by an increased lifetime risk of benign and malignant endocrine tumors in various organs. Data on quality of life (QoL) in patients with MEN1 are scarce, whereas QoL is considered an important treatment outcome.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author: Van Leeuwaarde R

Authors: Van Leeuwaarde R, Beijers H, de Herder W, Dekkers O, Van der Horst-Schrivers A,

Keywords: MEN1, QoL,